MyHealthChecked (MHC) Competitors GBX 10.28 -0.01 (-0.05%) As of 10:03 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock MHC vs. IHC, POLX, AVO, RUA, SUN, BELL, DEMG, SN, NIOX, and MXCTShould you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include Inspiration Healthcare Group (IHC), Polarean Imaging (POLX), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Belluscura (BELL), Deltex Medical Group (DEMG), Smith & Nephew (SN), NIOX Group (NIOX), and MaxCyte (MXCT). These companies are all part of the "medical devices" industry. MyHealthChecked vs. Its Competitors Inspiration Healthcare Group Polarean Imaging Advanced Oncotherapy RUA Life Sciences Surgical Innovations Group Belluscura Deltex Medical Group Smith & Nephew NIOX Group MaxCyte MyHealthChecked (LON:MHC) and Inspiration Healthcare Group (LON:IHC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends. Do institutionals and insiders believe in MHC or IHC? 0.5% of MyHealthChecked shares are owned by institutional investors. Comparatively, 20.1% of Inspiration Healthcare Group shares are owned by institutional investors. 9.3% of MyHealthChecked shares are owned by company insiders. Comparatively, 8.4% of Inspiration Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer MHC or IHC? In the previous week, MyHealthChecked's average media sentiment score of 0.00 equaled Inspiration Healthcare Group'saverage media sentiment score. Company Overall Sentiment MyHealthChecked Neutral Inspiration Healthcare Group Neutral Which has more risk & volatility, MHC or IHC? MyHealthChecked has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500. Comparatively, Inspiration Healthcare Group has a beta of 0.09, meaning that its stock price is 91% less volatile than the S&P 500. Is MHC or IHC more profitable? MyHealthChecked has a net margin of -11.06% compared to Inspiration Healthcare Group's net margin of -28.46%. MyHealthChecked's return on equity of -12.80% beat Inspiration Healthcare Group's return on equity.Company Net Margins Return on Equity Return on Assets MyHealthChecked-11.06% -12.80% -8.18% Inspiration Healthcare Group -28.46%-34.30%-3.47% Which has better valuation and earnings, MHC or IHC? MyHealthChecked has higher earnings, but lower revenue than Inspiration Healthcare Group. MyHealthChecked is trading at a lower price-to-earnings ratio than Inspiration Healthcare Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMyHealthChecked£3.61M1.48-£1.04M-£0.03-298.12Inspiration Healthcare Group£38.25M0.50-£12.20M-£0.19-112.43 SummaryMyHealthChecked beats Inspiration Healthcare Group on 7 of the 11 factors compared between the two stocks. Get MyHealthChecked News Delivered to You Automatically Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MHC vs. The Competition Export to ExcelMetricMyHealthCheckedMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£5.46M£2.57B£5.78B£2.57BDividend YieldN/A2.44%6.70%5.30%P/E Ratio-298.12265.0175.845,395.93Price / Sales1.48153.97538.9997,029.82Price / Cash1.7815.9925.7027.93Price / Book0.713.7511.917.98Net Income-£1.04M£132.05M£3.28B£5.89B7 Day Performance1.33%-2.93%1.11%0.63%1 Month Performance-6.50%-4.81%8.17%55.78%1 Year Performance-8.58%12.84%67.79%197.77% MyHealthChecked Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MHCMyHealthCheckedN/AGBX 10.290.0%N/A-8.5%£5.46M£3.61M-298.1216IHCInspiration Healthcare GroupN/AGBX 22.70-0.4%N/A-0.5%£20.26M£38.25M-120.62224High Trading VolumePOLXPolarean ImagingN/AGBX 0.95flatN/A-43.1%£11.47M£3.09M-86.3628Gap DownAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.20-7.6%N/A+0.5%£7.52M£4.11M-2.6148High Trading VolumeSUNSurgical Innovations GroupN/AGBX 0.67-4.9%N/A+2.6%£6.53M£11.95M-317.1480Gap UpBELLBelluscuraN/AGBX 0.75flatN/AN/A£3.01M£1.80M-5.7324DEMGDeltex Medical GroupN/AN/AN/AN/A£187K£1.76M-0.1537Gap UpHigh Trading VolumeSNSmith & Nephew2.9374 of 5 starsGBX 1,377-0.4%GBX 1,379.33+0.2%+18.1%£15.10B£7.08B49.5818,452High Trading VolumeNIOXNIOX Group1.7169 of 5 starsGBX 76+3.3%GBX 90+18.4%+10.8%£302.48M£41.80M9,156.6392High Trading VolumeMXCTMaxCyteN/AGBX 1.40+0.7%N/A-99.5%£170.11M£35.75M-3.5080High Trading Volume Related Companies and Tools Related Companies Inspiration Healthcare Group Competitors Polarean Imaging Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors Surgical Innovations Group Competitors Belluscura Competitors Deltex Medical Group Competitors Smith & Nephew Competitors NIOX Group Competitors MaxCyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MHC) was last updated on 9/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The $100 billion DeFi prediction nobody's talking about The numbers are staggering: $38.5 billion TVL, $1 m...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTime is running out on the most obvious trade in historyGold just broke out to fresh all-time highs, silver is up 40% this year, and for the first time in three decad...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyHealthChecked PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MyHealthChecked With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.